Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

K. Garey · SciRah

Researcher profile · Semantic Scholar

K. Garey

Share profile

K. Garey — researcher profile on SciRah

h-index: 54
Works: 454
Citations: 15K

Most-cited papers

Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies
A. Gonzales-Luna, T. Carlson, K. Garey
2023Gut microbes62 citations Open access
Semantic Scholar
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response
P. Okhuysen, M. Ramesh, T. Louie, N. Kiknadze +16 more
2024Clinical Infectious Diseases37 citations Open access
Semantic Scholar
Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical Trial
K. Garey, E. Dubberke, A. Guo, Adam J. Harvey +7 more
2023Open Forum Infectious Diseases35 citations Open access
Semantic Scholar
Reduced Vancomycin Susceptibility in Clostridioides difficile is Associated with Lower Rates of Initial Cure and Sustained Clinical Response.
Taryn A. Eubank, Chetna Dureja, K. Garey, J. Hurdle +1 more
2024Clinical Infectious Diseases33 citations Open access
Semantic Scholar
Emerging Options for the Prevention and Management of Clostridioides difficile Infection
A. Gonzales-Luna, T. Carlson, K. Garey
2023Drugs33 citations Open access
Semantic Scholar
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence.
A. Gonzales-Luna, T. Carlson, K. Garey
2023Clinical Infectious Diseases28 citations Open access
Semantic Scholar
Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109
K. Garey, Jin-Ung Jo, A. Gonzales-Luna, B. Lapin +14 more
2023JAMA Network Open25 citations Open access
Semantic Scholar
Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection.
T. Carlson, A. Gonzales-Luna, K. Garey
2022Seminars in Respiratory and Critical Care Medicine19 citations
Semantic Scholar
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile
E. Bassères, Taryn A. Eubank, K. Begum, M. J. Alam +5 more
2024Antimicrobial Agents and Chemotherapy18 citations Open access
Semantic Scholar
Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study
Taryn A. Eubank, Jin-Ung Jo, M. J. Alam, K. Begum +13 more
2025The Lancet Microbe15 citations Open access
Semantic Scholar
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort Study
Kaylee E. Caniff, N. Rebold, Xhilda Xhemali, Nikki Tran +31 more
2025Open Forum Infectious Diseases15 citations Open access
Semantic Scholar
Omadacycline and Clostridioides difficile: A Systematic Review of Preclinical and Clinical Evidence
K. Garey, W. Rose, K. Gunter, A. Serio +1 more
2022The Annals of Pharmacotherapy15 citations Open access
Semantic Scholar
Prebiotics Improve Blood Pressure Control by Modulating Gut Microbiome Composition and Function: A Systematic Review and Meta-Analysis
Abdulwhab Shremo Msdi, Elisabeth M. Wang, K. Garey
2025Nutrients14 citations
Semantic Scholar
A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020–2021
D. Snydman, L. McDermott, C. Thorpe, E. Goldstein +11 more
2023Antimicrobial Agents and Chemotherapy13 citations Open access
Semantic Scholar
Clostridioides difficile is a Bacterial Priority Pathogen.
W. Smits, K. Garey, T. Riley, Stuart Johnson
2025Anaerobe12 citations Open access
Semantic Scholar
Donor-recipient specificity and age-dependency in fecal microbiota therapy and probiotic resolution of gastrointestinal symptoms
Qing-Long Wu, Prapaporn Boonma, S. Badu, Nazlı Yalçınkaya +7 more
2023npj Biofilms and Microbiomes12 citations Open access
Semantic Scholar
Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection
P. Feuerstadt, J. Allegretti, E. Dubberke, Amy Guo +9 more
2024Infectious Disease and Therapy11 citations Open access
Semantic Scholar
Proton pump inhibitor effect on macrophage and neutrophil function: a systematic review
J. Fowler, Taryn A. Eubank, K. Garey
2024Frontiers in Immunology11 citations Open access
Semantic Scholar
Fidaxomicin resistance in Clostridioides difficile: a systematic review and predictive modeling with RNA polymerase binding sites
Thanh M. Le, Taryn A. Eubank, Ann M. McKelvey, Xin-Yuan Cao +2 more
2024Antimicrobial Agents and Chemotherapy11 citations Open access
Semantic Scholar
The Novel DNA Binding Mechanism of Ridinilazole, a Precision Clostridiodes difficile Antibiotic
C. Mason, T. Avis, Chenlin Hu, Nabeetha A. Nagalingam +12 more
2023Antimicrobial Agents and Chemotherapy11 citations Open access
Semantic Scholar
Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile
A. Olaitan, Chetna Dureja, Madison A. Youngblom, Madeline A. Topf +10 more
2023Nature Communications10 citations Open access
Semantic Scholar
The impact of ibezapolstat and other Clostridioides difficile infection-relevant antibiotics on the microbiome of humanized mice
Trenton M. Wolfe, Jin-Ung Jo, Nick V. Pinkham, K. Garey +1 more
2025Antimicrobial Agents and Chemotherapy9 citations Open access
Semantic Scholar
Redefining Clostridioides difficile infection antibiotic response and clinical outcomes.
A. Gonzales-Luna, Andrew M. Skinner, C. Alonso, E. Bouza +18 more
2023Lancet. Infectious Diseases (Print)9 citations Open access
Semantic Scholar
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers
Jin-Ung Jo, Chen-Lin Hu, K. Begum, Weiqun Wang +8 more
2023Journal of Infectious Diseases9 citations Open access
Semantic Scholar
Microbiome-Based Therapeutics for Salt-Sensitive Hypertension: A Scoping Review
Abdulwhab Shremo Msdi, A. Haghparast, K. Garey, Elisabeth M. Wang
2025Nutrients7 citations Open access
Semantic Scholar
Clostridioides difficile should be considered a bacterial priority pathogen.
W. Smits, K. Garey, T. Riley, Yi-Ping W. Han +6 more
2025The Lancet Microbe7 citations Open access
Semantic Scholar
Development and validation of LC-MS/MS for quantifying omadacycline from stool for gut microbiome studies.
Chen-Lin Hu, Weiqun Wang, Jin-Ung Jo, K. Garey
2024Journal of chromatography. B, Analytical technologies in the biomedical and life sciences7 citations Open access
Semantic Scholar
Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes
Taryn A. Eubank, Chetna Dureja, A. Gonzales-Luna, J. Hurdle +1 more
2024Open Forum Infectious Diseases7 citations Open access
Semantic Scholar
Increased Prevalence of Clostridioides difficile Infection Among Pediatric Oncology Patients: Risk Factors for Infection and Complications
Brianna R. Murphy, Natalie J. M. Dailey Garnes, H. Hwang, C. Peterson +2 more
2023The Pediatric Infectious Disease Journal7 citations
Semantic Scholar
Association between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes among Hospitalized Adult Patients with Candidemia Who Received Empiric Treatment with an Echinocandin Across United States Hospitals.
T. Lodise, K. Garey, Jalal A Aram, B. Nathanson
2025Clinical Infectious Diseases6 citations
Semantic Scholar
Emerging Clostridioides difficile ribotypes have divergent metabolic phenotypes
Firas S Midani, H. Danhof, Nathanael Mathew, Colleen K. Ardis +3 more
2024bioRxiv6 citations Open access
Semantic Scholar
Effectiveness of Continuous Glucose Monitoring in a Pharmacist-Run Collaborative Drug Therapy Management Service for Underserved Individuals With Diabetes: A Quasi-Experimental Study
Jodie S. Gee, Natalie Rosario, K. Garey, Bernadette Asias-Dinh
2025Clinical Diabetes5 citations
Semantic Scholar
Defining Fulminant Clostridioides difficile Infections: Assessing the Utility of Hypotension as a Diagnostic Criterion
Hubert C Chua, Taryn A. Eubank, Allen A. Lee, Krishna Rao +3 more
2025Open Forum Infectious Diseases5 citations Open access
Semantic Scholar
Detectable Vancomycin Stool Concentrations in Hospitalized Patients with Diarrhea Given Intravenous Vancomycin
Taryn A. Eubank, Chen-Lin Hu, A. Gonzales-Luna, K. Garey
2023Pharmacoepidemiology5 citations Open access
Semantic Scholar
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA
T. Tran, Nicolo L. Cabrera, A. Gonzales-Luna, T. Carlson +16 more
2022JAC-Antimicrobial Resistance5 citations Open access
Semantic Scholar
Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial
K. Garey, Jacob McPherson, An Q. Dinh, Chenlin Hu +9 more
2022Clinical Infectious Diseases5 citations Open access
Semantic Scholar
The microbiome-restorative potential of ibezapolstat for the treatment of Clostridioides difficile infection is predicted through variant PolC-type DNA polymerase III in Lachnospiraceae and Oscillospiraceae
Jacob K. McPherson, J. Hurdle, Matthew L. Baker, Tahir Hussain +2 more
2025Antimicrobial Agents and Chemotherapy4 citations Open access
Semantic Scholar
522. Significant Improvement in Health-Related Quality of Life (HRQL) with RBX2660: Results from a Phase 3 Randomized, Placebo-Controlled Trial in Recurrent Clostridioides Difficile Infection (PUNCH CD3)
P. Feuerstadt, E. Dubberke, A. Guo, Adam J. Harvey +6 more
2022Open Forum Infectious Diseases4 citations Open access
Semantic Scholar
Phase I trial comparing bile acid and short-chain fatty acid alterations in stool collected from human subjects treated with omadacycline or vancomycin
Jin-Ung Jo, Chen-Lin Hu, Thomas D. Horvath, S. Haidacher +3 more
2025Antimicrobial Agents and Chemotherapy3 citations Open access
Semantic Scholar
Candidiasis epidemiology and outcomes including emergence of Candida auris from a large, Southern US metro area: a six-year evaluation
Ricky Huynh-Phan, Ardath Plauche, William L. Musick, Kady Phe +6 more
2025Antimicrobial Stewardship and Healthcare Epidemiology3 citations Open access
Semantic Scholar
Emerging Clostridioides difficile ribotypes have divergent metabolic phenotypes
Firas S Midani, H. Danhof, Nathanael Mathew, Colleen K. Ardis +3 more
2025mSystems3 citations Open access
Semantic Scholar
Healthcare Resource Utilization and Discharge Readiness in Adult Hospitalized Patients With Candidemia or Invasive Candidiasis Who Received an Echinocandin: An Analysis of United States Hospitals
T. Lodise, K. Garey, Jalal A Aram, B. Nathanson
2024Open Forum Infectious Diseases3 citations Open access
Semantic Scholar
Effect of fecal microbial transplantation on Clostridioides difficile infection: dysbiosis, metabolites and health related quality of life
K. Garey, P. Feuerstadt, E. Dubberke, A. Guo +1 more
2023Open Forum Infectious Diseases3 citations Open access
Semantic Scholar
Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection
Thomas J. Sandora, L. Kociolek, David N Williams, Kaitlyn Daugherty +10 more
2023Infection control and hospital epidemiology3 citations Open access
Semantic Scholar
Surveillance of Clostridioides difficile antimicrobial resistance in the United States.
A. Gonzales-Luna, Chetna Dureja, Taryn A. Eubank, K. Garey +1 more
2023Clinical Infectious Diseases3 citations Open access
Semantic Scholar
Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial
Jin-Ung Jo, Travis J Carlson, Chen-Lin Hu, John C. Williamson +7 more
2025Journal of Antimicrobial Chemotherapy2 citations Open access
Semantic Scholar
Nonmammalian models to study Clostridioides difficile infection; a systematic review
Chenlin Hu, K. Garey
2023Anaerobe2 citations Open access
Semantic Scholar
Preservation of the Innate Immune Response to Clostridioides difficile Infection in Hospitalized Immunocompromised Patients
Marcela Banegas, Javier A. Villafuerte-Gálvez, R. Paredes, R. Sprague +11 more
2023Open Forum Infectious Diseases2 citations Open access
Semantic Scholar
S189 Efficacy and Safety of RBX2660 in Patients After First Recurrence of Clostridioides difficile Infection – Results From a Phase 3, Randomized, Placebo-Controlled Study
G. Tillotson, M. Ando, Lindy L. Bancke, Adam J. Harvey +2 more
2022American Journal of Gastroenterology2 citations
Semantic Scholar
Colitis caused by Clostridioides difficile infection in a domestic dog: A case report.
K. Rainha, Débora Lins, R. F. Ferreira, C. L. Costa +5 more
2022Anaerobe2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Gonzales-Luna×18
Invite
A. Gonzales-Luna — researcher profile on SciRah
Taryn A. Eubank×11
Invite
Taryn A. Eubank — researcher profile on SciRah
Jin-Ung Jo×10
Invite
Jin-Ung Jo — researcher profile on SciRah
K. Begum×7
Invite
K. Begum — researcher profile on SciRah

×7

Invite

M. J. Alam — researcher profile on SciRah

Invite

E. Dubberke — researcher profile on SciRah

Invite

J. Hurdle — researcher profile on SciRah

Invite

T. Carlson — researcher profile on SciRah

P. Feuerstadt×5

Invite

P. Feuerstadt — researcher profile on SciRah

Invite

Chen-Lin Hu — researcher profile on SciRah

Adam J. Harvey×4

Invite

Adam J. Harvey — researcher profile on SciRah

Lindy L. Bancke×4

Invite

Lindy L. Bancke — researcher profile on SciRah